Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Richard Ogawa

Richard Ogawa is recorded as Board Member and General Counsel at Palomino Laboratories Inc. (PALX). Palomino Laboratories Inc. reported in an 8-K filed October 6, 2025 that Richard Ogawa was appointed Secretary. Palomino Laboratories Inc. reported in an 8-K filed October 6, 2025 that Richard Ogawa was appointed directors of the Parent. Palomino Laboratories Inc. reported in an 8-K filed October 6, 2025 that Richard Ogawa was appointed Secretary, effective September 29, 2025. Equibles holds 4 filed executive changes naming Richard Ogawa; each is listed under recent activity with its source filing.

“evidence of the appointment of such executive officers of the Parent to serve immediately following the Effective Time as shall have been designated by the Company, including Jeff Shealy, President and Chief Executive Officer; Richard Ogawa, Secretary; and Jason Tu, Chief Accounting Officer”
Palomino Laboratories Inc. Form 8-K, filed October 6, 2025 · Read the filing
“evidence of the appointment, including the filing of a 14f-1 at least ten days prior to the anticipated Closing Date, of the following persons to serve as directors of the Parent effective as of the Effective Time: Jeff Shealy, Richard Ogawa, and Steve DenBaars”
Palomino Laboratories Inc. Form 8-K, filed October 6, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Palomino Laboratories Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.